LYRM7-associated mitochondrial complex III deficiency presenting as infantile hemiparesis with chronic cerebral infarction: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262668Keywords:
Mitochondrial oxidative phosphorylation, LYRM7, GeneAbstract
Mitochondrial oxidative phosphorylation (OXPHOS) disorders are rare genetic diseases that primarily affect organs with high energy demands, especially the brain. Although stroke-like episodes are recognised manifestations, presentation as chronic cerebral infarction in infancy is uncommon. Variants in the LYRM7 gene causing mitochondrial complex III deficiency are extremely rare. We report an infant who presented with an acute-onset right-sided hemiparesis following a febrile illness and was found to have a chronic left middle cerebral artery territory cerebral infarction on neuroimaging. The child had delayed developmental milestones, elevated serum lactate, and magnetic resonance spectroscopy findings suggestive of mitochondrial dysfunction. Whole-exome sequencing identified a pathogenic homozygous variant in the LYRM7 gene, confirming mitochondrial complex III deficiency. Supportive management and multidisciplinary rehabilitation resulted in gradual improvement in motor function and developmental progress in follow-up. This case broadens the phenotypic spectrum of LYRM7-associated mitochondrial disease by presenting an unusual case. Recognition of mitochondrial disorders in infants presenting with stroke-like neurological deficits is essential for timely genetic diagnosis, appropriate management, family counselling, and long-term follow-up.
References
Lax NZ, Gorman GS, Turnbull DM. Review: Central nervous system involvement in mitochondrial disease. Neuropathol Appl Neurobiol. 2017;43:102-18.
Fernandez-Vizarra E, Zeviani M. Mitochondrial disorders of the OXPHOS system. FEBS Lett. 2021;595:1062-106.
Invernizzi F, Tigano M, Dallabona C, Donnini C, Ferrero I, Cremonte M, et al. A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis, and severe reduction of mitochondrial complex III activity. Hum Mutat. 2013;34:1619-22.
Luke ND, Vijayakrishnan Nair A, Sivadasan A, Muthusamy K, Thomas MM, Yoganathan S, et al. A novel presentation and variable phenotypic spectrum of homozygous start-loss variant in LYRM7-associated mitochondrial complex III deficiency. Am J Med Genet A. 2025;197:e64105.
Khan GS, Bayat S, Azizimalamiri R, Nikoohemmat M, Mashayekhi N, Nabilou S, et al. Expanding the clinical spectrum of LYRM7-associated mitochondrial complex III deficiency: insights from new cases and literature review. J Mol Neurosci. 2026;76:72.
Kirby DM, Thorburn DR. Approaches to finding the molecular basis of mitochondrial oxidative phosphorylation disorders. Twin Res Hum Genet. 2008;11:395-411.
Alfattal R, Alfarhan M, Algaith AM, Albash B, Elshafie RM, Alshammari A, et al. LYRM7-associated mitochondrial complex III deficiency with non-cavitating leukoencephalopathy and stroke-like episodes. Am J Med Genet A. 2023;191:1401-11.
Hempel M, Kremer LS, Tsiakas K, Alhaddad B, Haack TB, Löbel U, et al. LYRM7-associated complex III deficiency: A clinical, molecular genetic, MR tomographic, and biochemical study. Mitochondrion. 2017;37:55-61.
Tabarki B, Hakami W, Alkhuraish N, Graies-Tlili K, Nashabat M, Alfadhel M. Inherited metabolic causes of stroke in children: mechanisms, types, and management. Front Neurol. 2021;12:633119.
Finsterer J, Zarrouk-Mahjoub S. Cerebral imaging in paediatric mitochondrial disorders. Neuroradiol J. 2018;31:596-608.